Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000318306-18-000004
Filing Date
2018-05-21
Accepted
2018-05-21 18:12:14
Documents
1
Period of Report
2018-05-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1423
  Complete submission text file 0000318306-18-000004.txt   3124
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address THE EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 6902 NEW YORK NY 10118
Business Address
Buono Stefano (Reporting) CIK: 0001665113 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 18850895